2nd Quarter - Report
MEHLMAN CONSULTING, INC. for MAYO CLINIC
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health care. General health reform implementation. Health care value and quality. Drug shortage issues. H.R. 5651, The Food and Drug Administration Reform Act of 2012 S. 3187, The Food and Drug Administration Safety and Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Medicare/Medicaid MMM
Quality payments for providers. Accountable care organizations. Clinical laboratory reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Medical/Disease Research/Clinical Labs MED
NIH appropriations Clinical laboratory reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.